Desmopressin acetate use in von Willebrand's disease: a survey on current practices in Brazil
Hematol., Transfus. Cell Ther. (Impr.); 43 (1), 2021
ABSTRACT Introduction: von Willebrand's disease (VWD) is the most common inherited bleeding disorder. The 1-desamino-8-d-arginine vasopressin (DDAVP) is the treatment of choice for most responsive patients with VWD. The aim of this study was to evaluate DDAVP use in the management of VWD. Method: We im...